NVAX

Novavax (NVAX) Stock Price

Closed
NVAX
$7.44
-$0.26(-3.37%)

Content updated: 2026-11-22 22:48:03

Yesterday's Close
$7.70
Today's Open
$7.59
Today's High
$7.96
Today's Low
$7.42
Volume
4.08M shares
52-Week Range
$6.71-$13.34

As of 2026-11-22 22:48:03, Novavax (NVAX) was quoted at $7.44, a change of -$0.26 (-3.37%) from the previous close. The day's range was $7.42–$7.96, and the 52-week range was $6.71–$13.34.

Past 1W-11.29%Period Low $7.37Period High $8.62
Past 1M-30.44%Period Low $7.37Period High $11.40
Past 3M-15.94%Period Low $7.37Period High $13.34

About Novavax (NVAX)

Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The company holds a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of its COVID-19 vaccine candidate, NVX-CoV2373. Established in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland.
Ticker / Exchanges
NVAX / NASDAQ
Industry / Sector
Biotechnology / Healthcare
CEO
John Charles Jacobs
Headquarters
Gaithersburg,MD,US
Official Website
https://www.novavax.com
Listing Date
1995-12-05

Recent Company Events

  • 2026-08-05
    Earnings Report · ExpectedOn 2026-08-05, the 2026/Q2 earnings report is expected to be released.

Novavax (NVAX) Derivatives Trading

NVAXTrade
CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

Novavax (NVAX) Company Financials

Valuation and Shares

Market Cap
--
P/E Ratio (TTM)
--
P/B Ratio
--
Shares Outstanding
--
Float Shares
--
Dividend Yield (TTM)
--

Latest Reported Financials

2026 Q1 Financials

Report Release Date: 2026-05-06

Operating Revenue (Actual)

$139.51M

Same Period Last Year: -79.07%

Earnings per Share (Actual)

-$0.06

Same Period Last Year: --

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$1.59B$556.38M$682.16M$1.12B
Net Profit-$657.93M-$545.06M-$187.49M$440.30M
Operating Cash Flow-$415.93M-$713.96M-$87.26M-$244.63M

NVAX FAQ

What is the current stock price of Novavax (NVAX)?

x
As of 2026-11-22 22:48 (UTC+8), the latest available quote for Novavax (NVAX) is $7.44 USD, with a change of -$0.26 USD (-3.37%) from the previous trading day's close. Current market status: Closed.

Which exchange is NVAX listed on?

x

How has Novavax stock performed over the past month?

x

What is the market cap of Novavax?

x

What are Novavax's latest financial results?

x

What factors may affect the stock price of Novavax (NVAX)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.